Medplus Health Services growth ratios

·Consumer ServicesChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+12.3%+9.1%+23.4%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+24.7%+37.6%+33.3%
+36.8%+82.7%+54.4%
+46.2%+129.1%+30.9%
+45.8%+129.4%+31.4%
+17.0%+11.8%+7.4%
+13.5%+10.3%+5.8%
−8.3%+276.0%+59.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MEDPLUS₹598.05

Medplus Health Services Ltd.

· Consumer Services
₹ CrorePeersAPOLLOHOSPMANYAVARMSTCLTDNESCOJUSTDIALJSLLQUESSIXIGOMcap ₹7,180 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—+23.4+9.1+12.3—
EBITDA Growth—+33.3+37.6+24.7—
EBIT Growth—+54.4+82.7+36.8—
Net Income Growth—+30.9+129.1+46.2—
EPS Growth—+31.4+129.4+45.8—
Total Assets Growth—+7.4+11.8+17.0—
Total Equity Growth—+5.8+10.3+13.5—
Cash from Operations Growth—+59.0+276.0-8.3—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.